Cargando…
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
Francisella tularensis subspecies tularensis is a category-A biothreat agent that can cause lethal tularemia. Ceftobiprole medocaril is being explored as a medical countermeasure for the treatment of pneumonic tularemia. The efficacy of ceftobiprole medocaril against inhalational tularemia was evalu...
Autores principales: | Hahn, Mark M., Triplett, Cheryl A., Anderson, Michael S., Smart, Jennifer I., Litherland, Karine, Keech, Stephen, von Siebenthal, Franziska, Jones, Mark, Phipps, Andrew J., Henning, Lisa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451734/ https://www.ncbi.nlm.nih.gov/pubmed/37627757 http://dx.doi.org/10.3390/antibiotics12081337 |
Ejemplares similares
-
Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022) -
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
por: Torres, Antonio, et al.
Publicado: (2016) -
Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021) -
Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021) -
2561. Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies
por: Cammarata, Anthony P, et al.
Publicado: (2023)